RxDoctor Payments Data

Lindsey Axt, PA

Physician Assistant · Brooklyn, NYNPI 1356759732

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $32,839 of the $51,643 with a category attached, or 63.6%. 33 manufacturers reported payments, led by AbbVie at 42.7% of the total. 2025 is the largest year on record at $24,609, more than ten times the $1,385 reported in 2021. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,643in general payments, 2019–2025

Across 861 payments — averaging $59.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$22K
  • Johnson & Johnson$18K
  • Sanofi$2K
  • Lilly USA, LLC$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Incyte Corporation$939
  • plus $7K from 27 others

What the payments were for

  • Consulting fees$1,9304%
  • Speaking & faculty fees$32,83964%
  • Travel & lodging$2,0344%
  • Food & beverage$14,30228%
  • Education$5391%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,643 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$40,816
Medicare patients
155
Services billed
568

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$44,518
Dupixent PenDupilumab11$40,366
Tacrolimus36$7,342
Clobetasol Propionate75$2,373
Fluocinonide26$1,615
Pimecrolimus13$1,577
Tretinoin15$1,313
Triamcinolone Acetonide90$1,065
CiclopiroxCiclopirox Olamine31$975
Clindamycin Phosphate44$970
Econazole Nitrate17$683
Ketoconazole49$679
Mometasone Furoate30$600
Ammonium Lactate12$410
Doxycycline Hyclate17$379

Paid to pharmacies, not to this prescriber.

Other physician assistant in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →